About EUPROTEIN
EUPROTEIN is a Healthcare company based in North Brunswick (United States) founded in 2013 by Guangli Wang, and was acquired by Meridian Life Science in May 2022. It operates as a customized bioresearch reagents are supplied for drug discovery. The company was acqui-hired. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Reagents and Kits and Proteomics. Its competitors include PrognomiQ, PreOmics, Vivostat, LenioBio and Expedeon and 4 more; 7 of its 9 listed competitors have raised funding.
Company details
EUPROTEIN was established in 2013 in North Brunswick, United States, as a provider in the biotechnology sector. Customized mammalian proteins and recombinant monoclonal antibodies are developed through its platform to support drug discovery and development. Services encompass protein production, antibody engineering, and cell line development, with operations centered on bioresearch reagents for research applications.
- Headquarters North Brunswick, United States
- Founders Guangli Wang
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website euprotein.com
- Social LinkedIn
- Acquired by Meridian Life Science (May 2022)
- Investors
- Acquired byMeridian Life Science
(May 2022)
Investors in EUPROTEIN
EUPROTEIN has secured backing from 1 investor. Prominent investors backing the company include Meridian Life Science.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Produces high-quality antibodies, viral antigens, recombinant proteins, and assay reagents. | 1983 | meridianlifescience.com | Memphis, United States |
Investor details for EUPROTEIN
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of EUPROTEIN
1 people are tracked at EUPROTEIN (1 in leadership).
| Name | Role | Group |
|---|---|---|
Guangli Wang | Founder | Leadership |
Complete people profiles for EUPROTEIN
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of EUPROTEIN
2 dated milestones of EUPROTEIN across 9 years, from founding to its latest funding, stage changes and deals.
- Founded EUPROTEIN is founded.
- Exit Acquired by Meridian Life Science.
Competitors of EUPROTEIN
EUPROTEIN has 9 listed competitors in our database, 7 of them funded. They include PrognomiQ, PreOmics, Vivostat, LenioBio and Expedeon, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| prognomiq.com | 2020 | San Mateo, United States | $90.36M | 24 | Developer of tests for the detection and treatment of cancer and other diseases | |
| preomics.com | 2014 | Munich, Germany | $19.14M | 22 | Reagents and instruments for proteomics research are supplied by PreOmics. | |
| vivostat.com | 2001 | Alleroed, Denmark | $12.89M | 9 | On-site fibrin sealant preparation systems are developed and provided. | |
| leniobio.com | 2016 | Dusseldorf, Germany | $13.01M | 18 | Kits for cell-free eukaryotic protein expression are provided. | |
| expedeon.com | 2003 | Swavesey, United Kingdom | $390,000 | 1,587 | Reagents and kits for protein-based research are developed and supplied. | |
| listlabs.com | 1978 | Campbell, United States | $48.4M | – | Specializes in the production of research reagents | |
| mjbiopharm.com | 2002 | Mumbai, India | $9.13M | 265 | Animal and human rDNA Insulin products and dosage forms | |
| acrobiosystems.com | 2016 | Newark, United States | – | 22 | Recombinant proteins are manufactured to support cancer immunotherapy efforts. | |
| anshlabs.com | 2010 | Webster, United States | – | 33 | Immunoassay reagents and kits are developed for life science research. |
Detailed competitors of EUPROTEIN
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
10 companies that operate in the same segment as EUPROTEIN (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | 1,111 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Euprotein
Complete news archive for EUPROTEIN
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about EUPROTEIN
EUPROTEIN was founded in 2013.
EUPROTEIN is headquartered in North Brunswick, United States. It is registered at North Brunswick, New Jersey, United States.
EUPROTEIN was established in 2013 in North Brunswick, United States, as a provider in the biotechnology sector. Customized mammalian proteins and recombinant monoclonal antibodies are developed through its platform to support drug discovery and development. Services encompass protein production, antibody engineering, and cell line development, with operations centered on bioresearch reagents for research applications.
EUPROTEIN has 1 investor. Key investors include Meridian Life Science.
Yes. EUPROTEIN was acquired by Meridian Life Science in May 2022.